| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LCI | LANNETT CO INC | Director | $2.75M | Nov 10, 2022 | ||
| VYNE | VYNE Therapeutics Inc. | Director | $150K | +$43.8K | +41.1% | Jan 15, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|